59729-33-8
59729-33-8
Chemical Structure
Citalopram
- CAS No.: 59729-33-8
- Formula:C20H21FN2O
- Molecular Weight:324.39
IUPAC Name: 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile
InChIKey: WSEQXVZVJXJVFP-UHFFFAOYSA-N
SMILES: N#CC1=CC=C2C(CCCN(C)C)(OCC2=C1)C3=CC=C(C=C3)F
Biological Activity: Citalopram is a racemate mixture of the active S(+)-enantiomer (Escitalopram; HY-14258) and R(-)-enantiomer. Citalopram is an orally active selective serotonin reuptake inhibitor (SSRI). Citalopram is an antidepressant and enhances serotoninergic neurotransmission[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Citalopram | 99.78% | Citalopram is a racemate mixture of the active S(+)-enantiomer (Escitalopram; HY-14258) and R(-)-enantiomer. Citalopram is an orally active selective serotonin reuptake inhibitor (SSRI). Citalopram is an antidepressant and enhances serotoninergic neurotransmission. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Citalopram (Standard) | ≥98% | Citalopram (Standard) is the analytical standard of Citalopram. This product is intended for research and analytical applications. Citalopram is a racemate mixture of the active S(+)-enantiomer (Escitalopram; HY-14258) and R(-)-enantiomer. Citalopram is an orally active selective serotonin reuptake inhibitor (SSRI). Citalopram is an antidepressant and enhances serotoninergic neurotransmission. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Citalopram-d3 hydrochloride | Citalopram-d3 hydrochloride is deuterated labeled Citalopram (HY-121203). Citalopram is a racemate mixture of the active S(+)-enantiomer (Escitalopram; HY-14258) and R(-)-enantiomer. Citalopram is an orally active selective serotonin reuptake inhibitor (SSRI). Citalopram is an antidepressant and enhances serotoninergic neurotransmission. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Citalopram-d6 | Citalopram-d6 is the deuterium labeled Citalopram. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Citalopram-d4 oxalate | Citalopram-d4 (oxalate) is the deuterium labeled Citalopram oxalate (HY-121203A). Citalopram is a racemate mixture of the active S(+)-enantiomer (Escitalopram; HY-14258) and R(-)-enantiomer. Citalopram is an orally active selective serotonin reuptake inhibitor (SSRI). Citalopram is an antidepressant and enhances serotoninergic neurotransmission. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Citalopram-d6 oxalate | Citalopram-d6 oxalate is the deuterium labeled Citalopram oxalate. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Carlsson B, et al. Enantioselective analysis of citalopram and escitalopram in postmortem blood together with genotyping for CYP2D6 and CYP2C19. J Anal Toxicol. 2009;33(2):65-76. [Content Brief]
- [2]. Milne RJ, et al. Citalopram. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Drugs. 1991;41(3):450-477. [Content Brief]
- [3]. Laurent Sakka, et al. Assessment of citalopram and escitalopram on neuroblastoma cell lines. Cell toxicity and gene modulation. Oncotarget. 2017 Jun 27;8(26):42789-42807. [Content Brief]
